Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 EPS of $0.19
Tweet Send to a FriendGet Alerts LGND Hot Sheet
Price: $27.38 -1.3%
Revenue Growth %: +108.9%
Financial Fact:
Income (loss) from continuing operations: 1.3M
Today's EPS Names:
NED, OESX, WSTL, More
Revenue Growth %: +108.9%
Financial Fact:
Income (loss) from continuing operations: 1.3M
Today's EPS Names:
NED, OESX, WSTL, More
Trade LGND Now!
Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q4 EPS of $0.19, versus $0.22 reported last year. Revenue for the quarter came in at $13.6 million, versus $12.9 million reported last year.
For earnings history and earnings-related data on Ligand Pharmaceuticals, Inc. (LGND) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Ligand Pharmaceuticals, Inc. (LGND) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Semtech Corp (SMTC) Reports In-Line Q1 EPS, Offers Q2 Guidance
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
